Analysis of effects of the herbal preparation circulat on gene expression levels in cultured human fibroblasts

Phytotherapy Research

Volumn 21, Issue 8, 2007, Pages 777-789

  Antoshechkin, A ^a   Olalde, J ^b   Magarici, M ^b   Muhammad, A ^b   Salom, A ^b   Suarez, J ^b   Amendola, F ^b  

^a Genext Research Inc   (United States)

^b Adaptogenic Medical Center   (Venezuela)

Author keywords

Adaptogens; Diabetes; Gene expression; Systemic

Indexed keywords

CIRCULAT; COMPLEMENT COMPONENT C4A; HERBACEOUS AGENT; HIGH MOBILITY GROUP A1A PROTEIN; INTERLEUKIN 16; OLIGONUCLEOTIDE; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ENERGY METABOLISM; FIBROBLAST; GENE EXPRESSION; GLUCOSE METABOLISM; HUMAN; HUMAN CELL; MICROARRAY ANALYSIS; NECROSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; PROTEIN SYNTHESIS; SIGNAL TRANSDUCTION;

CELL LINE; FIBROBLASTS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; PLANT PREPARATIONS; PLANTS, MEDICINAL;

EID: 34547692944     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.2174     Document Type: Article

References (12)

1. Ashburner M, Ball CA, Blake JA et al. 2000. The Gene Ontology Consortium. Gene ontology: tool for the unification of biology. Nature Genet 25: 25-29.
2. Chesney MA, Straus SE. 2004. Complementary and alternative medicine: the convergence of public interest and science in the United States. Med J Aust 181: 335-336.
3. Foti D, Chiefari E, Fedele M et al. 2005. Lack of the architectural factor HMGA1 causes insulin resistance and diabetes in humans and mice. Nat Med 11: 765-773.
4. Katz S, Harris R, Lau JT, Chau A. 2006. The use of gene expression analysis and proteomic databases in the development of a screening system to determine the value of natural medicinal products. Evid Based Complement Alternat Med 3: 65-70.
5. Kristiansen OP, Mandrup-Poulsen T. 2005. Interleukin-6 and diabetes: the good, the bad, or the indifferent? Diabetes (Suppl) 2: S114-S124.
6. Labay V, Raz T, Baron D et al. 1999. Mutations in SLC19A2 cause thiamine-responsive megaloblastic anaemia associated with diabetes mellitus and deafness. Nat Genet 22: 300-304.
7. Mashkovsky MD. 1984. Medicinal Remedies. Medicina: Moscow, Volume 1, 139-141.
8. Olalde Rangel JA, Magarici M, Amendola F, del Castillo O. 2005. The systemic theory of living systems. Part IV: Systemic medicine - the praxis. Evid Based Complement Alternat Med 2: 429-439.
9. Palsdottir A, Cross SJ, Edwards JH, Carroll MC. 1983. Correlation between a DNA restriction fragment length polymorphism and C4A6 protein. Nature 306(5943): 615-616.
10. Sreekumar R, Halvatsiotis P, Schimke JC, Nair KS. 2002. Gene expression profile in skeletal muscle of type 2 diabetes and the effect of insulin treatment. Diabetes 51: 1913-1920.
11. Steinmann GG, Esprester A, Joller P. 2001. Immunopharmacological in vitro effects of Eleutherococcus senticosus extract. Arzneimittelforschung 51: 76-83.
12. Thomas CW, Myhre GM, Tshumper R et al. 2005. Selective inhibition of inflammatory gene expression in activated T lymphocytes: a mechanism of immune suppression by thiopurines. J Pharmacol Exp Ther 312: 537-545.